BioRem Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 3.17 million compared to CAD 4.38 million a year ago. Net loss was CAD 0.557492 million compared to CAD 0.101003 million a year ago.

Basic loss per share from continuing operations was CAD 0.036 compared to CAD 0.007 a year ago. Diluted loss per share from continuing operations was CAD 0.036 compared to CAD 0.007 a year ago.